GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,923 | -2,995 | -2,333 | -1,700 | -2,099 |
| Depreciation Amortization | 90 | 472 | 390 | 232 | 321 |
| Other Working Capital | 1,648 | 78 | 157 | 145 | -49 |
| Other Operating Activity | 38 | 910 | 628 | 555 | 1,328 |
| Operating Cash Flow | $-147 | $-1,535 | $-1,158 | $-768 | $-499 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 94 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 46 | 46 | 46 | 46 |
| Other Financing Activity | 0 | 250 | 0 | 0 | 0 |
| Financing Cash Flow | $94 | $296 | $46 | $46 | $46 |
| Beginning Cash Position | 54 | 1,293 | 1,293 | 1,293 | 1,293 |
| End Cash Position | 1 | 54 | 181 | 571 | 840 |
| Net Cash Flow | $-53 | $-1,239 | $-1,112 | $-722 | $-453 |
| Free Cash Flow | |||||
| Operating Cash Flow | -147 | -1,535 | -1,158 | -768 | -499 |
| Free Cash Flow | -147 | -1,535 | -1,158 | -768 | -499 |